pVITRO1-102.1F10-IgG1/λ Citations (4)
Originally described in: A tool kit for rapid cloning and expression of recombinant antibodies.Dodev TS, Karagiannis P, Gilbert AE, Josephs DH, Bowen H, James LK, Bax HJ, Beavil R, Pang MO, Gould HJ, Karagiannis SN, Beavil AJ Sci Rep. 2014 Jul 30;4:5885. doi: 10.1038/srep05885. PubMed Journal
Articles Citing pVITRO1-102.1F10-IgG1/λ
Articles |
---|
Integrated Genome and Protein Editing Swaps alpha-2,6 Sialylation for alpha-2,3 Sialic Acid on Recombinant Antibodies from CHO. Chung CY, Wang Q, Yang S, Yin B, Zhang H, Betenbaugh M. Biotechnol J. 2016 Dec 12. doi: 10.1002/biot.201600502. PubMed |
Staphylococcus aureus Decolonization of Mice With Monoclonal Antibody Neutralizing Protein A. Chen X, Sun Y, Missiakas D, Schneewind O. J Infect Dis. 2019 Feb 23;219(6):884-888. doi: 10.1093/infdis/jiy597. PubMed |
Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies. Chen X, Shi M, Tong X, Kim HK, Wang LX, Schneewind O, Missiakas D. Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22992-23000. doi: 10.1073/pnas.2003621117. Epub 2020 Aug 27. PubMed |
Engineered human antibodies for the opsonization and killing of Staphylococcus aureus. Chen X, Schneewind O, Missiakas D. Proc Natl Acad Sci U S A. 2022 Jan 25;119(4). pii: 2114478119. doi: 10.1073/pnas.2114478119. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.